The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Metopirone 250mg Soft capsules

HRA Pharma Rare DiseasesPA22888/001/001

Main Information

Trade NameMetopirone 250mg Soft capsules
Active SubstancesMetyrapone
Dosage FormCapsule, soft
Licence HolderHRA Pharma Rare Diseases
Licence NumberPA22888/001/001

Group Information

ATC CodeV04CD Tests for pituitary function
V04CD01 metyrapone


License statusAuthorised
Licence Issued03/02/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back